http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 30 Apr 2026 11:47:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752 http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- Made Scientific, a <location value="LC/us" idsrc="xmltag.org" >U.S.</location>-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued build-out of its Board of Directors, including the appointment of <person>Ted Dolan</person> and <location>Soyoung Park</location>. They join <person>Jin Pyun</person>, <person>Harry S. Rathore</person>, Ph.D., and <person>Yonghoon Kim</person>, alongside Chairman and CEO <person>Syed T. Husain</person>, as part of a deliberate effort to align the company's governance with its next phase of growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Made+Scientific+Strengthens+Board+to+Support+Scale-Up+and+Commercial+Readiness+in+Cell+Therapy+Manufacturing/26404048.html Thu, 30 Apr 2026 11:47:00 -0400 A.04515188 A.13155924 A.15376238 A.29111803 A.37405616 A.38534015 A.50200193 A.50201916 A.50210774 HLTH O.00189094 O.00448140 O.00786254 O.01202496 O.07508089 O.26301655 O.37903257 O.39095467 O.40847752